AbbVie

A–Z catalog of AbbVie’s currently marketed medicines

A

• Actigall / Urso / Urso Forte — Ursodiol — Gallstones, PBC — ~10 mg/kg/day in divided doses.

• Actonel / Atelvia — Risedronate — Osteoporosis, Paget’s — 35 mg once weekly (Atelvia DR weekly/monthly).

• Acular — Ketorolac ophthalmic 0.5% — Post-op ocular pain/inflammation — 1 drop QID.

• Acular LS — Ketorolac 0.4% — Ocular pain — 1 drop QID.

• Acuvail — Ketorolac 0.45% — Post-op ocular pain — 1 drop BID.

• Alphagan — Brimonidine 0.2% — Glaucoma/ocular HTN — 1 drop TID.

• Alphagan-P — Brimonidine 0.1–0.15% — Glaucoma/ocular HTN — 1 drop TID.

• Aluvia — Lopinavir/ritonavir — HIV — 400/100 mg BID with food (global brand for Kaletra).

• AndroGel 1% — Testosterone — Hypogonadism — 5 g gel daily (50 mg), titrate.

• AndroGel 1.62% — Testosterone — Hypogonadism — 40.5–81 mg gel daily (per label).

B

• Belkyra — Deoxycholic acid — Submental fat (Canada/ROW name of Kybella) — 0.2 mL per injection grid; per protocol.

• Bentyl — Dicyclomine — IBS cramping — 20 mg QID (titrate/limit per tolerability).

• Botox (Therapeutic) — OnabotulinumtoxinA — Chronic migraine, spasticity, detrusor overactivity, CD, etc. — Doses by indication (e.g., 155 U q12w for migraine).

• Botox Cosmetic — OnabotulinumtoxinA — Facial lines — Site-dependent dosing (e.g., 20 U glabellar).

• Bystolic — Nebivolol — Hypertension — 5–10 mg QD (range 2.5–40 mg).

C

• Canasa — Mesalamine suppositories — Ulcerative proctitis — 1 g PR HS.

• Carafate — Sucralfate — Duodenal ulcer — 1 g QID before meals & HS.

• Combigan — Brimonidine/timolol — Glaucoma/ocular HTN — 1 drop BID.

• Constella — Linaclotide — IBS-C/CIC (EU name of Linzess) — 290 µg QD (IBS-C); 145 µg QD (CIC, per label).

• Creon — Pancrelipase — Exocrine pancreatic insufficiency — 25–50k lipase units with meals; 10–25k with snacks.

• Crinone — Progesterone vaginal gel 4/8% — Luteal support/ART — 90 mg QD–BID per regimen.

D

• Dalvance — Dalbavancin — ABSSSI — 1,000 mg IV Day 1, then 500 mg Day 8 or 1,500 mg single dose.

• Delzicol — Mesalamine DR — Ulcerative colitis — e.g., 800 mg TID (per strength/label).

• Depakote / Depakote ER — Divalproex — Epilepsy, bipolar, migraine prevention — Individualized; ER 500–2,000 mg/day.

• Durysta — Bimatoprost intracameral implant — Glaucoma/ocular HTN — 10 µg single implant per eye (per label).

• Duodopa — Carbidopa/levodopa intestinal gel (ex-US brand of Duopa) — Advanced Parkinson’s — Continuous intestinal infusion via pump.

• Duopa — Carbidopa/levodopa intestinal gel — Advanced Parkinson’s — Continuous infusion; titrated by response.

E

• Elahere — Mirvetuximab soravtansine — FRα-positive ovarian cancer — 6 mg/kg IV q3w (adj. by AIBW).

• Epkinly — Epcoritamab — DLBCL/FL (relapsed/refractory) — SC step-up then maintenance (per protocol).

• Estrace (tablets) — Estradiol — Menopausal symptoms — 0.5–2 mg QD.

• Estrace (vaginal cream) — Estradiol 0.01% — Atrophic vaginitis — 2–4 g QD, then maintenance.

• Estradiol Valerate/other E2 products (regional Allergan legacy brands) — Menopause — Per local label.

• Eszopiclone (regional legacy brand portfolios) — Insomnia — 1–3 mg HS (if applicable).

F

• Fetzima — Levomilnacipran ER — Major depression — 40–120 mg QD.

• Femhrt — Ethinyl estradiol/norethindrone — HRT — 1 tab QD (per strength).

• Fortesta (regional) — Testosterone 2% gel — Hypogonadism — 40–70 mg QD (per label).

• Forest legacy COCs (regional) — EE/progestin combos — Contraception — 1 tab QD (per brand/strength).

G

• Gengraf — Cyclosporine microemulsion — Transplant — ~5–6 mg/kg/day in 2 doses, titrate.

• Generess Fe — EE/norethindrone chewable — Contraception — 1 tab QD cyclic.

• Gelnique 10% — Oxybutynin gel — OAB — 1 sachet QD to thighs/abdomen/upper arms.

• Glecaprevir/Pibrentasvir (Mavyret/Maviret) — HCV — 300/120 mg (3 tabs) QD with food 8–12 wks.

• Ganfort — Bimatoprost/timolol — Glaucoma/ocular HTN — 1 drop QD.

• Gatifloxacin (Zymaxid/Zymar) — Gatifloxacin ophthalmic — Bacterial conjunctivitis — 1 drop q2h then QID (per label).

• Gralise (regional legacy) — Gabapentin ER — PHN — Titrated to 1,800 mg QD with evening meal.

• Gildagia/other HRT combos (regional) — Menopause — Per local label.

H

• Humira — Adalimumab — IMIDs (RA, PsA, AS, psoriasis, IBD, uveitis, etc.) — 40 mg SC q2w (varies by indication).

I

• Imbruvica — Ibrutinib — CLL/SLL, MCL, WM, MZL — 420–560 mg QD (indication-specific).

• Invibe (regional aesthetics kits) — OnabotulinumtoxinA delivery/ancillaries — See Botox dosing (kit ancillary).

• Iluvien-related (note: not AbbVie; excluded elsewhere) — — —

J

• Juvéderm Ultra XC — Hyaluronic acid filler — Facial lines — Inject per plane/volume; per IFU.

• Juvéderm Ultra Plus XC — HA filler — Deeper folds — Per IFU.

• Juvéderm Voluma XC — HA filler — Cheek/chin augmentation — Per IFU.

• Juvéderm Volux XC — HA filler — Jawline — Per IFU.

• Juvéderm Volbella XC — HA filler — Lips/perioral lines — Per IFU.

• Juvéderm Vollure XC — HA filler — Nasolabial folds — Per IFU.

• Juvéderm Volite (ex-US) — HA skin-quality — Micro-aliquots per IFU.

• Skinvive by Juvéderm — HA microdroplet — Skin hydration/quality — Microdroplet technique per IFU.

K

• Kaletra — Lopinavir/ritonavir — HIV — 400/100 mg BID with food.

• Kybella — Deoxycholic acid — Submental fat — 0.2 mL per injection site; grid-based protocol.

• KyBella variants (vial sizes) — Deoxycholic acid — As above — Per vial size/IFU.

L

• Latisse — Bimatoprost 0.03% — Hypotrichosis of eyelashes — Apply once HS to upper lash line.

• Lastacaft — Alcaftadine 0.25% — Allergic conjunctivitis — 1 drop QD.

• Lexapro — Escitalopram — MDD, GAD — 10–20 mg QD.

• Liletta (device; usually excluded) — — —

• Linzess — Linaclotide — IBS-C (290 µg QD); CIC (145 µg QD).

• Lo Loestrin Fe — EE/norethindrone + iron — COC — 1 tab QD cyclic.

• Loestrin 24 Fe — EE/norethindrone + iron — COC — 1 tab QD cyclic.

• Lumigan 0.01% — Bimatoprost — Glaucoma/ocular HTN — 1 drop HS.

• Lumigan 0.03% (ex-US) — Bimatoprost — Glaucoma — 1 drop HS.

• Lupron Depot — Leuprolide acetate — Prostate cancer, endometriosis, fibroids — IM depot monthly/3-/6-month strengths per regimen.

• Lupron Depot-Ped — Leuprolide — Central precocious puberty — Weight-based IM depot per schedule.

• Lupaneta Pack — Leuprolide + norethindrone acetate — Endometriosis — Packaged regimens per label.

• Linzess Starter/maintenance packs — Linaclotide — IBS-C/CIC — As above.

• Loprox (topical ciclopirox; regional legacy) — Ciclopirox — Dermatomycoses — BID (per label).

• Lutera/legacy COCs (regional) — EE/levonorgestrel — COC — 1 tab QD cyclic.

M

• Mavyret — Glecaprevir/Pibrentasvir — HCV — See G (3 tabs QD with food, 8–12 wks).

• Maviret — Glecaprevir/Pibrentasvir (ex-US name) — HCV — As above.

• Minastrin 24 Fe — EE/norethindrone chewable + iron — COC — 1 tab QD cyclic.

• Mesalamine enemas (Rowasa brand/legacy) — Mesalamine 4 g/60 mL — Distal UC — 1 enema HS.

N

• Namenda — Memantine — Alzheimer’s — 10 mg BID (titrated).

• Namenda XR — Memantine ER — Alzheimer’s — 28 mg QD (titrated).

• Namzaric — Donepezil/memantine ER — Alzheimer’s — 10/28 mg QD (after stabilization).

• Norvir — Ritonavir — HIV booster — 100 mg QD–BID (per regimen).

O

• Oriahnn — Elagolix/estradiol/norethindrone — Fibroid-related heavy bleeding — 300/1/0.5 mg AM + 300 mg PM.

• Orilissa — Elagolix — Endometriosis pain — 150 mg QD (≤24 mo) or 200 mg BID (≤6 mo).

• Oxytrol Rx — Oxybutynin transdermal — OAB — Patch twice weekly.

• Oxytrol for Women (OTC) — Oxybutynin patch — OAB — Patch twice weekly.

• Ozurdex — Dexamethasone intravitreal implant — Macular edema, uveitis — Single implant per IFU; repeat per label.

• Ophthalmic steroid combos (Blephamide, etc.) — Sulfacetamide/prednisolone — Ocular inflammation with bacterial component — 1–2 drops q4–6h (per label).

P

• Pred Forte — Prednisolone acetate 1% — Ocular inflammation — 1–2 drops q4–6h (then taper).

• Pred Mild — Prednisolone acetate 0.12% — Mild ocular inflammation — 1–2 drops QID.

• Pazeo/Pataday legacy (regional rights vary) — Olopatadine — Allergic conjunctivitis — 1 drop QD–BID (per strength/label).

• PPI/sucralfate combos (regional) — Per local — Dyspepsia/ulcer support — Per label.

• Progesterone/estrogen HRT packs (legacy) — Per components — HRT — Per label.

Q

• Qulipta — Atogepant — Migraine prevention — 10–60 mg QD (per indication/country).

R

• Rapaflo — Silodosin — BPH — 8 mg QD with food.

• Rectiv — Nitroglycerin 0.4% ointment — Anal fissure pain — 1-inch strip q12h intra-anal.

• Refresh Tears — Lubricant eye drops — Dry eye — 1–2 drops PRN.

• Refresh Optive — Lubricant drops — Dry eye — 1–2 drops PRN.

• Refresh Optive Advanced — Lubricant drops — Dry eye — 1–2 drops PRN.

• Refresh Optive Mega-3 — Lubricant drops with flaxseed oil — Dry eye — 1–2 drops PRN.

• Refresh Relieva / Relieva PF — Lubricant drops — Dry eye — 1–2 drops PRN.

• Refresh Plus / Celluvisc / Gel Drops / PM — Lubricants/gel/ointment — Dry eye/nighttime — As directed.

• Restasis — Cyclosporine 0.05% emulsion — Chronic dry eye (tear deficiency) — 1 drop BID OU.

• Restasis Multidose — Cyclosporine 0.05% — As above — 1 drop BID OU.

• Rinvoq — Upadacitinib — RA, PsA, AD, UC, CD, axSpA — 15 mg QD (some indications 30 mg QD).

S

• Saphris — Asenapine SL — Schizophrenia, bipolar I — 5–10 mg BID SL.

• Savella — Milnacipran — Fibromyalgia — 50 mg BID (after titration).

• Skyrizi — Risankizumab — Psoriasis (SC 150 mg at 0,4 wks then q12w); IBD includes IV induction per label.

• Synthroid — Levothyroxine — Hypothyroidism — ~1.6 µg/kg/day QD; titrate q4–6 wks.

• Sucralfate Suspension — Sucralfate 1 g/10 mL — Ulcers — 10 mL QID before meals & HS.

• Sodium Hyaluronate eye lubricants (Refresh variants) — Sodium hyaluronate-based — Dry eye — Per product.

• Silodosin caps (strength variants) — Silodosin — BPH — 4–8 mg QD (per strength/renal).

• Sevorane — Sevoflurane (global brand of Ultane) — General anesthesia — Inhalation per MAC/titration.

T

• Taytulla — Norethindrone acetate/EE + ferrous fumarate — COC — 1 cap QD cyclic.

• Teflaro — Ceftaroline fosamil — CAP/ABSSSI — 600 mg IV q12h.

• Technivie — Ombitasvir/paritaprevir/ritonavir — HCV (± RBV) — As per genotype regimen.

• TriCor — Fenofibrate — Hypertriglyceridemia/mixed dyslipidemia — 145 mg QD (formulation-specific).

• Trilipix — Fenofibric acid — Hypertriglyceridemia — 135 mg QD.

• Timolol/combination glaucoma drops (Combigan et al.) — Per product — Glaucoma/ocular HTN — Per label.

• Topical ophthalmic steroids (Pred Forte/Pred Mild) — Prednisolone acetate — Ocular inflammation — As above.

U

• Ubrelvy — Ubrogepant — Acute migraine — 50–100 mg once; may repeat ≥2 h (max 200 mg/day).

• Ultane — Sevoflurane — General anesthesia — 1–3% inspired (titrated to effect/MAC).

• Urso / Urso Forte — Ursodiol — PBC/gallstones — ~10 mg/kg/day divided.

V

• Venclexta — Venetoclax — CLL/SLL, AML (± combos) — Ramp-up then 400 mg QD (varies by regimen).

• Viberzi — Eluxadoline — IBS-D — 100 mg BID with food (75 mg in select patients).

• Viibryd — Vilazodone — Major depression — 20–40 mg QD with food.

• Vraylar — Cariprazine — Schizophrenia, bipolar I, adjunctive MDD — 1.5–6 mg QD.

• Vyalev — Foscarbidopa/foslevodopa — Parkinson’s motor fluctuations — Continuous SC infusion via pump; titrate.

• Viekira Pak — Ombitasvir/paritaprevir/ritonavir + dasabuvir — HCV GT1 — Fixed regimen per label.

• Viekira XR — Ombitasvir/paritaprevir/ritonavir/dasabuvir ER — HCV GT1 — Once-daily dosing per label.

• Volbella/Voluma/Volux/Vollure (see Juvéderm family) — HA fillers — Facial augmentation — Per IFU.

• Viokace — Pancrelipase (non-enteric) — EPI (with PPI) — Dosed by lipase units with meals.

• Vascular/oculoplastic adjuncts (Ozurdex, etc.) — Dexamethasone implant — As above.

W / X / Y / Z

• Zymaxid — Gatifloxacin 0.5% ophthalmic — Bacterial conjunctivitis — 1 drop q2h while awake, then QID (per label).

• Zymar (where marketed) — Gatifloxacin 0.3% — Bacterial conjunctivitis — Per label.